Why the study?
Does heparin therapy cause hyperkalemia in susceptible patients?
Does heparin therapy cause hyperkalemia in susceptible patients?
Clinicians should be aware that heparin can induce hyperkalemia via hypoaldosteronism, especially in patients with diabetes or renal insufficiency.
Answers are grounded in this paper and cite their sources.
Warrants early potassium monitoring in heparin-treated patients with diabetes or renal insufficiency; leaves open prospective incidence studies.
Heparin-induced hypoaldosteronism leading to hyperkalemia is an uncommon adverse effect. It appears as though heparin blocks an enzymatic step in the synthesis of aldosterone, and reduced aldosterone levels may be evident as early as four days after initiation of therapy. Although all patients who receive heparin may have reduced aldosterone levels, most are able to compensate through increased renin production and therefore remain asymptomatic. However, patients on prolonged heparin therapy or those unable to adequately increase renin production (e.g., patients with diabetes or renal insufficiency) may exhibit signs of hypoaldosteronism, such as hyperkalemia.
No takes yet. Share an insight, caveat, or question.
Larry Aull (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: